Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 5.95%572.241.0%$894.82m
DHRDanaher Corp. 5.90%266.550.7%$728.82m
ABTAbbott Laboratories 1.53%116.630.8%$667.08m
MDTMedtronic Plc -0.21%99.230.6%$533.64m
ISRGIntuitive Surgical, Inc. 2.62%229.160.8%$507.57m
ALGNAlign Technology, Inc. 3.54%284.576.4%$385.17m
BSXBoston Scientific Corp. 2.72%41.231.0%$373.14m
IDXXIDEXX Laboratories, Inc. 3.56%398.613.8%$371.22m
SYKStryker Corp. 0.65%236.471.3%$338.97m
DXCMDexCom, Inc. 3.01%289.087.7%$331.07m
BDXBecton, Dickinson & Co. 1.52%256.331.0%$308.87m
EWEdwards Lifesciences Corp. 2.50%101.030.4%$306.41m
AAgilent Technologies, Inc. 5.40%130.541.6%$281.49m
BAXBaxter International, Inc. 0.63%76.231.8%$243.16m
MTDMettler-Toledo International, Inc. 5.32%1325.465.8%$206.58m

Company Profile

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.